Course outcome
V PHARM. D
PHARMACOEPIDEMIOLOGY AND PHARMACOECONOMICS (THEORY)
After a successful completion of the course the students will be able to
Course outcome number | Course Outcomes | Cognitive level |
CO1 | Students will be able to Recall the definition and scope of pharmacoepidemiology, List the aims and applications of pharmacoepidemiology,Identify different outcome measures and drug use measures used in pharmacoepidemiology. | C1 |
CO2 |
Students will Explain the concept of risk in pharmacoepidemiology. Describe the methods used in pharmacoepidemiological studies, including their theoretical aspects. Differentiate between prevalence, incidence, and incidence rate. |
C2 |
CO3 |
Students will Apply the measurement techniques for medication adherence. Use various pharmacoepidemiological methods to analyze real-life case studies. Apply the concept of relative risk, attributable risk, and odds ratio to evaluate pharmacoepidemiological data. |
C3 |
CO4 |
Analyze different sources of data for pharmacoepidemiological studies, including ad hoc data sources and automated data systems. Critically evaluate the strengths and weaknesses of various pharmacoepidemiological methods. Analyze the relevance of pharmacoepidemiology in the context of special applications, such as vaccine safety and hospital pharmacoepidemiology. |
C4 |
CO5 |
Evaluate the role of pharmacoeconomic evaluations in formulary management decisions. Critically assess the outcomes of different pharmacoeconomic evaluation methods, including cost-minimization, cost-benefit, cost-effectiveness, and cost-utility. Evaluate the significance and implications of pharmacoepidemiology and risk management, especially in relation to drug-induced birth defects. |
C5 |
CO6 |
Develop a comprehensive understanding of pharmacoeconomics and its historical evolution. Create a pharmacoeconomic evaluation for a specific drug or intervention, considering various outcome assessments. Synthesize the knowledge gained from the course to effectively utilize pharmacoeconomic software and analyze case studies in the context of healthcare decision-making. |
C6 |